Go to the list of all blogs
Dem Sem's Avatar
published in Blogs
Jul 27, 2023
AI Trader's Winning Streak: $ABBV Profits Jump +3.98% in 7 Days

AI Trader's Winning Streak: $ABBV Profits Jump +3.98% in 7 Days

One such innovation is the emergence of AI trading robots that promise to navigate the complexities of the stock market and deliver substantial returns. In this article, we analyze the recent performance of an AI trading robot accessible at "Day Trader: High Volatility Stocks for Active Trading (TA&FA)" and explore how it generated an impressive +3.98% gain while trading ABBV during the previous week. Additionally, we examine the company's momentum indicator and its implications for potential traders.

AI Trading Robot Performance

The "Day Trader: High Volatility Stocks for Active Trading (TA&FA)" AI trading robots have caught the attention of investors with their remarkable performance. During the past week, these bots demonstrated their capabilities by achieving a significant +3.98% gain while trading ABBV, a pharmaceutical company known for its innovative products and steady growth.

Analyzing the Momentum Indicator

One crucial tool employed by traders to gauge a stock's potential momentum is the Momentum Indicator. On July 11, 2023, ABBV's Momentum Indicator surpassed the 0 level, signaling the possibility of a new upward trend for the stock. Traders are likely to interpret this as an opportunity to consider buying the stock or buying call options, expecting a positive price movement.

To gain further insight, Tickeron's A.I.dvisor analyzed 79 similar instances where ABBV's Momentum Indicator turned positive. The findings revealed that in 53 out of the 79 cases, the stock moved higher in the subsequent days. Based on this historical data, the odds of ABBV moving higher after the positive Momentum Indicator reading are calculated to be at an encouraging 67%.

Earnings Results

In addition to the Momentum Indicator, earnings reports play a pivotal role in influencing a company's stock performance. ABBV's last earnings report on April 27 showcased earnings per share (EPS) of $2.46, meeting the estimated value of $2.46. With 1.55 million shares outstanding, this performance led to a current market capitalization of approximately $252.61 billion.

The fact that ABBV met earnings estimates can instill confidence in investors and may support the positive momentum indicated by the AI trading robots. Strong earnings are often perceived as a sign of a company's fundamental strength, attracting more investors and potentially leading to increased demand for the stock.

Summary

AI trading robots have proven their worth in the stock market, and the "Day Trader: High Volatility Stocks for Active Trading (TA&FA)" bots are no exception. Their impressive +3.98% gain while trading ABBV highlights the potential these AI-driven tools hold in generating profits for investors.

Moreover, ABBV's Momentum Indicator moving above the 0 level on July 11, 2023, suggests a potential shift towards an upward trend. Past instances of similar positive Momentum Indicators further reinforce the probability of ABBV experiencing an upward movement, with odds reaching as high as 67%.

Additionally, ABBV's last earnings report meeting the estimated EPS value reflects positively on the company's financial performance, bolstering investor confidence in the stock's future prospects.

Related Ticker: ABBV

ABBV sees its Stochastic Oscillator climbs out of oversold territory

On June 22, 2026, the Stochastic Oscillator for ABBV moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 54 instances where the indicator left the oversold zone. In of the 54 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 22, 2026. You may want to consider a long position or call options on ABBV as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ABBV just turned positive on June 23, 2026. Looking at past instances where ABBV's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for ABBV crossed bullishly above the 50-day moving average on May 20, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ABBV advanced for three days, in of 360 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 351 cases where ABBV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ABBV moved out of overbought territory on June 08, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 43 similar instances where the indicator moved out of overbought territory. In of the 43 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABBV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ABBV broke above its upper Bollinger Band on June 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 65, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ABBV's P/B Ratio (243.902) is very high in comparison to the industry average of (19.568). ABBV's P/E Ratio (112.750) is considerably higher than the industry average of (26.482). Projected Growth (PEG Ratio) (0.634) is also within normal values, averaging (15.849). Dividend Yield (0.029) settles around the average of (0.031) among similar stocks. P/S Ratio (6.494) is also within normal values, averaging (3.939).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. ABBV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), AstraZeneca PLC (NYSE:AZN), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), Biogen (NASDAQ:BIIB).

Industry description

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

Market Cap

The average market capitalization across the Pharmaceuticals: Major Industry is 184.65B. The market cap for tickers in the group ranges from 72.83K to 987.23B. LLY holds the highest valuation in this group at 987.23B. The lowest valued company is CRXTQ at 72.83K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Major Industry was 3%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was 3%. MDCX experienced the highest price growth at 34%, while SNY experienced the biggest fall at -5%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Major Industry was 64%. For the same stocks of the Industry, the average monthly volume growth was 93% and the average quarterly volume growth was 154%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 24
P/E Growth Rating: 61
Price Growth Rating: 49
SMR Rating: 52
Profit Risk Rating: 65
Seasonality Score: 10 (-100 ... +100)
View a ticker or compare two or three
ABBV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a research-based pharmaceutical company

Industry PharmaceuticalsMajor

Profile
Details
Industry
Pharmaceuticals Major
Address
1 North Waukegan Road
Phone
+1 847 932-7900
Employees
50000
Web
http://www.abbvieinvestor.com
Interact to see
Advertisement
In the ever-shifting healthcare sector, CVS Health (CVS) and UnitedHealth Group (UNH) represent two powerhouse approaches: CVS as a retail pharmacy giant with integrated insurance and services, and UNH as a leading health insurer with diversified operations.
In the competitive retail landscape, American Eagle Outfitters (NYSE: AEO) is showing signs of robust upward potential as it navigates a strong 2025 performance.
In the dynamic world of satellite communications and broadband services, EchoStar Corporation (NASDAQ: SATS) has captured investor attention with a notable technical breakthrough. On December 8, 2025, the stock's 10-day moving average crossed above its 50-day moving average, signaling the onset of a bullish upward trend.
In an era where global investors demand instant access to markets, major players in the financial world are racing to extend trading hours beyond the traditional 9:30 a.m. to 4 p.m. ET window. This push is driven by surging foreign holdings of U.S. equities, which hit $17 trillion last year, and the growing appetite for nonstop trading in a 24/7 digital economy.
In the resilient gold mining sector, IAMGOLD Corporation (NYSE: IAG) has demonstrated an extraordinary uptrend throughout 2025, capitalizing on rising gold prices and operational milestones.
Within the rapidly evolving automotive retail landscape, Carvana Co. (NYSE: CVNA) has emerged as one of 2025’s standout performers. Once viewed as a highly volatile name, the company has transformed into a market leader as demand for online vehicle purchasing accelerates
Microsoft (MSFT) emerges as the AI-favored stock in 2025, outperforming Apple (AAPL) with a 16% year-to-date gain, compared to Apple’s 10% rise. The advantage stems from Microsoft’s deeper enterprise AI integration, accelerating cloud growth, and scalable software ecosystem.
ExxonMobil (XOM) emerges as the AI-preferred energy stock in 2025, posting a 10% year-to-date gain compared with Chevron’s (CVX) 2% increase. Stronger upstream production, exposure to high-growth assets, and expanding low-carbon initiatives support XOM’s momentum. Tickeron’s AI models signal continued upside for XOM, while CVX shows signs of overbought conditions and elevated downside risk.
Tesla (TSLA) emerges as the AI-preferred EV stock in 2025, posting a 19% year-to-date gain, while BYD (BYDDY) has declined 82%, reflecting diverging momentum across the global EV market. Tickeron’s AI trading bots indicate strong bullish conditions for TSLA, supported by positive momentum signals, whereas BYDDY shows sustained bearish trends.
Broadcom (AVGO) emerges as the AI-preferred semiconductor stock in 2025, posting a 48% year-to-date gain, compared with 37% for NVIDIA (NVDA), supported by stronger diversification across networking, infrastructure, and custom AI chips.
- Bio-Techne carries a “Moderate Buy” consensus from 13 analysts, with an average price target of $70.58, implying about 15% upside. - Recent positive revisions include TD Cowen (Oct. 14, target raised from $65 to $70, Strong Buy), Evercore ISI (Oct. 7, $60 to $72, Buy), and RBC -
Skyworks Solutions (SWKS) has traded unevenly in recent weeks as investors digest shifting sector dynamics and company-specific guidance. The stock has moved into a consolidation phase following broader semiconductor rotations, with optimism in diversified end markets offset by ongoing pressure in mobile.
Seagate Technology (STX) has emerged as one of the standout performers of 2025, powered by explosive demand for data storage tied to artificial intelligence workloads. As hyperscalers expand cloud and AI infrastructure, Seagate’s high-capacity hard drives have become essential, pushing the stock sharply higher and keeping investor attention firmly locked on upcoming earnings.
Home Depot and Lowe’s are the two dominant players in the home improvement retail space, frequently compared due to their similar product offerings and overlapping customer bases of DIY homeowners and professional contractors. Their performance is closely watched as a barometer for consumer discretionary spending, housing market trends, and interest rate impacts.
Over the past month, Wynn’s share price has been shaped by a combination of analyst actions, expansion-related news, and shifting industry dynamics. The stock reached a 52-week high in early December, supported by positive premarket activity and renewed optimism across consumer-facing sectors.
Visa (V) strengthened its leadership in global payments, advancing AI-driven tools, stablecoin advisory services, and enhanced security offerings in 2025.
Goldman Sachs and Morgan Stanley are leading global investment banks, frequently compared due to their overlapping operations in capital markets, wealth management, and advisory services. Evaluating these stocks side by side helps investors and traders understand differences in risk, growth potential, and revenue drivers amid ongoing macroeconomic shifts, tariff impacts, and a resurgence in deal-making activity.
Equinox Gold (EQX) and Coeur Mining (CDE) are notable players in the precious metals mining sector, focusing on gold and silver production in a market influenced by economic uncertainty, inflation hedges, and global demand. This comparison provides insight for investors tracking commodity trends or seeking safe-haven assets.
Strategic Acquisitions and Expansion: USAR acquired UK-based Less Common Metals, integrating rare earth metal and magnet production to create a comprehensive magnet-to-mine supply chain. Production Acceleration: Construction at the Round Top facility in Texas has been advanced, with commercial production now expected by late 2028—two years ahead of the original schedule.